Team of Biotech professionals having expertise with Sequence listing standards
Our work is not DONE until you are 100% satisfied.
The World Intellectual Property Organization (WIPO) has introduced a new sequence listing standard, ST.26, which provides a uniform format for submitting nucleotide and/or amino acid
Patent applications in the biotechnology domain require a detailed sequence listing, which is a critical part of the patent application process. These listings are essential
The world of intellectual property is vast and complex. Various standards and guidelines ensure to document these inventions and innovations correctly. Specifically, in the realm
Sequence listings are an essential part of biotech patent applications. They list nucleotide and/or amino acid sequences associated with the invention. These sequence listings assist
Biotechnology patent applications often involve nucleotide and amino acid sequences that require proper disclosure to obtain IP protection. The sequence listing is a standardized document
All patent applications specifying nucleotide or amino acid sequences must include a sequence listing. The World Intellectual Property Organization (WIPO) has set forth international standards